ABUS is creating volatility contraction pattern
Fib level as of what i see now at .786 looks to be right here. its also where prior resistance may turn into support for the price. also the 200 sma has had time to catch up to the price of the stock and can be another indicator for the patient people on the sidelines that the chart has leveled off for now.
This stock has potential to retest $12.60.
Arbutus Biopharma Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of a cure for patients suffering from chronic Hepatitis B virus (HBV) infection in the United States. Its HBV product pipeline consists of AB-836, a capsid inhibitor that has the potential to inhibit HBV replication by preventing the assembly of...
Like how this chart is setting up with slight options activity Friday.
All, Amazing setup just need to make sure it holds. Buy in 1.26 (unless this breaks above) Should get some gains if everything goes well.
Bullish golden cross Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company is headquartered in Burnaby, Canada.
Why do these bio's keep catching me. Hate bio's! but like to gamble. One might hold this a week or week and a half. Break out.
Let's see how far this one drop and wait for signal when to buy.
ABUS broke the resistance line and floating over the support line. Expecting a line comeback to support line or ex-resistance-new-support line (they might converge) to fuel up before the big leap. A touch on the midline would be enough to get on the train.